ARLINGTON, Va.--(BUSINESS WIRE)--Surescripts®, the nation's leading health information network, has now expanded its innovative Sig IQ technology, first introduced for Medication History in 2022, to E ...

Surescripts, a health information network, has expanded its Sig IQ technology, first introduced for Medication History in 2022, to E-Prescribing transactions, including NewRx and both RxRenewal ...

ARLINGTON, Va.-- (BUSINESS WIRE)--Surescripts is again bringing innovation to the prescribing process with its new Specialty Patient Enrollment service, which helps prescribers, specialty hubs and ...

GoodRx has entered into an agreement with Surescripts, to deliver drug discount price information to prescribers using Surescripts Real-Time Prescription Benefit when prescribing medications for ...

LAS VEGAS—A new analysis finds that more pharmacists are electronically prescribing medications as they assist in managing chronic disease, which offers a peek at the next evolution in primary care.

ARLINGTON, Va.--(BUSINESS WIRE)-- Surescripts, the nation’s leading health information network, has broadened its partnership with PointClickCare, the leading cloud-based software for the senior care ...

Surescripts, the country’s largest health information exchange network, has identified 10 hospitals and health systems that demonstrate best practices in e-prescribing. “Surescripts is proud that our ...

Surescripts, a health information network focused on e-prescriptions, filed a motion July 12 to dismiss the FTC’s charge from April that the company used illegal tactics to develop monopolies over two ...

GoodRx struck a deal with medication data giant Surescripts to provide doctors and clinicians with more information about drug discount prices for select patients at the point of care. The partnership ...

The settlement comes after a federal court determined that Surescripts holds a 95% 'supershare' for e-prescribing services. The Federal Trade Commission announced Thursday that it has reached a ...

The lawsuit alleged the health IT vendor monopolized e-prescription drug markets for routing and eligibility through exclusivity agreements, threats and other exclusionary conduct. The FTC first ...